Patients Coming Off Slimming Injections Put On Pounds at a Quadrupled Rate Than Dieters

Fresh analysis indicates that people who come off new weight-loss injections like Wegovy and Mounjaro may regain reduced body mass far faster than those who end traditional diet and exercise plans.

Published data in a major health publication shows that while obese people can lose substantial amounts of their body weight while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month after stopping.

"Individuals purchasing such drugs must be cognizant of the risk of quick rebound weight gain when the therapy ends," stated lead investigator Dr. Susan Jebb.

That rate of recovery means a return to starting weight within about 18 months.

Comparing Approaches

The analysis, which reviewed 37 of trials involving over 9,000 of participants, compared the outcomes of GLP-1 agonists with older methods.

Researchers emphasize that individuals who shed pounds through diet and exercise usually experience a less rapid creep back—around 100 grams monthly—post-intervention.

Understanding the Fast Regain

Doctors suggest the mechanism of the jabs explains the amplified rebound.

GLP-1 drugs imitate a body's own chemical called GLP-1, which moderates appetite.

"Artificially providing the hormone concentrations several times higher than normal might result in the body to produce less of its own natural GLP-1, and could diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.

"Stopping of this medication means hunger is uncontrolled, making overeating far more likely."

A Lifelong Condition?

The NHS suggest the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

Many experts argue that, due to the high risk of weight regain, the treatment might need to be life-long.

This view is supported by drug manufacturers, who say that the results "emphasize the long-term character of excess weight," comparing it to managing conditions like high blood pressure.

User Experiences

Individuals who have discontinued the jabs explain a intense return of hunger.

"It felt as if a switch activating and you become ravenous," recalled an individual.

The struggle is exacerbated if users have not adopted lasting lifestyle or habit changes during therapy.

Significant Use

Recent estimates indicate that a significant number of adults in the UK have tried these injections in the past year, with desire being substantial.

• Adoption is greater among women than men.
• The middle-aged age group shows the highest level of interest.
• A large proportion obtain the medications through private prescriptions rather than public health services.

Ultimately, clinicians emphasize that while these medications are powerful agents for shedding pounds, they are not a permanent fix and maintained weight loss likely depends on integrated lifestyle support.